Modulation of μ-mediated antinociception by δ agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalin

Julius S. Heyman, Jeffry L. Vaught, Henry I. Mosberg, Ronald C. Haaseth, Frank Porreca

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The effect of the δ-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) on the antinociception produced by intracerebroventricular (i.c.v.) administration of the μ agonists morphine, [D-Ala2, NMePhe4,Gly-ol5]enkephalin (DAGO), [NMePhe3,D-Pro4]morphiceptin (PLO17), β-endorphin, phenazocine, etorphine and sufentanil was studied in mice. Only the antinociceptive effects of morphine and normorphine were modulated by i.c.v. coadministration of a dose of DPDPE which did not prodice any significant antinociception alone. Both the morphine and normorphine dose-response lines were displaced to the left in the presence of DPDPE. The δ-selective antagonist ICII74,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH) (where Aib is α-aminoisobutyric acid) blocked the modulation of morphine antinociception by DPDPE. ICI 174,864 alone failed to produce either a significant increase or decrease of morphine, phenazocine, etorphine or β-endorphin antinociception. The results of the present study provide support for the hypothesis that the enkephalins may function to modulate antinociception produced at the μ receptor; such modulation may come about via the existence of an opioid μ-δ receptor complex. The μ receptors existing in such a complex may be selectively activated by morphine and normorphine, but not the other μ agonists studied here. Thus, the enkephalins may function both to directly initiate, as well as to modulate, some forms of supraspinal μ receptor-mediated antinociception.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalEuropean Journal of Pharmacology
Volume165
Issue number1
DOIs
StatePublished - Jun 8 1989

Fingerprint

D-Penicillamine (2,5)-Enkephalin
Morphine
Phenazocine
Etorphine
Endorphins
Enkephalins
Aminoisobutyric Acids
Sufentanil
Opioid Receptors
normorphine

Keywords

  • (Intracerebroventricular, Mouse)
  • Opioid antinociception
  • δ Receptors
  • μ Receptors

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Modulation of μ-mediated antinociception by δ agonists in the mouse : selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalin. / Heyman, Julius S.; Vaught, Jeffry L.; Mosberg, Henry I.; Haaseth, Ronald C.; Porreca, Frank.

In: European Journal of Pharmacology, Vol. 165, No. 1, 08.06.1989, p. 1-10.

Research output: Contribution to journalArticle

@article{05c8540dcc144582a261b8d221655af9,
title = "Modulation of μ-mediated antinociception by δ agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalin",
abstract = "The effect of the δ-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) on the antinociception produced by intracerebroventricular (i.c.v.) administration of the μ agonists morphine, [D-Ala2, NMePhe4,Gly-ol5]enkephalin (DAGO), [NMePhe3,D-Pro4]morphiceptin (PLO17), β-endorphin, phenazocine, etorphine and sufentanil was studied in mice. Only the antinociceptive effects of morphine and normorphine were modulated by i.c.v. coadministration of a dose of DPDPE which did not prodice any significant antinociception alone. Both the morphine and normorphine dose-response lines were displaced to the left in the presence of DPDPE. The δ-selective antagonist ICII74,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH) (where Aib is α-aminoisobutyric acid) blocked the modulation of morphine antinociception by DPDPE. ICI 174,864 alone failed to produce either a significant increase or decrease of morphine, phenazocine, etorphine or β-endorphin antinociception. The results of the present study provide support for the hypothesis that the enkephalins may function to modulate antinociception produced at the μ receptor; such modulation may come about via the existence of an opioid μ-δ receptor complex. The μ receptors existing in such a complex may be selectively activated by morphine and normorphine, but not the other μ agonists studied here. Thus, the enkephalins may function both to directly initiate, as well as to modulate, some forms of supraspinal μ receptor-mediated antinociception.",
keywords = "(Intracerebroventricular, Mouse), Opioid antinociception, δ Receptors, μ Receptors",
author = "Heyman, {Julius S.} and Vaught, {Jeffry L.} and Mosberg, {Henry I.} and Haaseth, {Ronald C.} and Frank Porreca",
year = "1989",
month = "6",
day = "8",
doi = "10.1016/0014-2999(89)90764-4",
language = "English (US)",
volume = "165",
pages = "1--10",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Modulation of μ-mediated antinociception by δ agonists in the mouse

T2 - selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalin

AU - Heyman, Julius S.

AU - Vaught, Jeffry L.

AU - Mosberg, Henry I.

AU - Haaseth, Ronald C.

AU - Porreca, Frank

PY - 1989/6/8

Y1 - 1989/6/8

N2 - The effect of the δ-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) on the antinociception produced by intracerebroventricular (i.c.v.) administration of the μ agonists morphine, [D-Ala2, NMePhe4,Gly-ol5]enkephalin (DAGO), [NMePhe3,D-Pro4]morphiceptin (PLO17), β-endorphin, phenazocine, etorphine and sufentanil was studied in mice. Only the antinociceptive effects of morphine and normorphine were modulated by i.c.v. coadministration of a dose of DPDPE which did not prodice any significant antinociception alone. Both the morphine and normorphine dose-response lines were displaced to the left in the presence of DPDPE. The δ-selective antagonist ICII74,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH) (where Aib is α-aminoisobutyric acid) blocked the modulation of morphine antinociception by DPDPE. ICI 174,864 alone failed to produce either a significant increase or decrease of morphine, phenazocine, etorphine or β-endorphin antinociception. The results of the present study provide support for the hypothesis that the enkephalins may function to modulate antinociception produced at the μ receptor; such modulation may come about via the existence of an opioid μ-δ receptor complex. The μ receptors existing in such a complex may be selectively activated by morphine and normorphine, but not the other μ agonists studied here. Thus, the enkephalins may function both to directly initiate, as well as to modulate, some forms of supraspinal μ receptor-mediated antinociception.

AB - The effect of the δ-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) on the antinociception produced by intracerebroventricular (i.c.v.) administration of the μ agonists morphine, [D-Ala2, NMePhe4,Gly-ol5]enkephalin (DAGO), [NMePhe3,D-Pro4]morphiceptin (PLO17), β-endorphin, phenazocine, etorphine and sufentanil was studied in mice. Only the antinociceptive effects of morphine and normorphine were modulated by i.c.v. coadministration of a dose of DPDPE which did not prodice any significant antinociception alone. Both the morphine and normorphine dose-response lines were displaced to the left in the presence of DPDPE. The δ-selective antagonist ICII74,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH) (where Aib is α-aminoisobutyric acid) blocked the modulation of morphine antinociception by DPDPE. ICI 174,864 alone failed to produce either a significant increase or decrease of morphine, phenazocine, etorphine or β-endorphin antinociception. The results of the present study provide support for the hypothesis that the enkephalins may function to modulate antinociception produced at the μ receptor; such modulation may come about via the existence of an opioid μ-δ receptor complex. The μ receptors existing in such a complex may be selectively activated by morphine and normorphine, but not the other μ agonists studied here. Thus, the enkephalins may function both to directly initiate, as well as to modulate, some forms of supraspinal μ receptor-mediated antinociception.

KW - (Intracerebroventricular, Mouse)

KW - Opioid antinociception

KW - δ Receptors

KW - μ Receptors

UR - http://www.scopus.com/inward/record.url?scp=0024355211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024355211&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(89)90764-4

DO - 10.1016/0014-2999(89)90764-4

M3 - Article

C2 - 2548877

AN - SCOPUS:0024355211

VL - 165

SP - 1

EP - 10

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -